Navigation Links
Alexza Reports 2011 First Quarter Financial Results and Provides Business Update
Date:5/9/2011

ing a plan to address these issues, and currently projects a resubmission of the AZ-004 NDA in July 2011.  

For more information about Alexza, the Staccato technology or the Company's development programs, please visit www.alexza.com.

Safe Harbor Statement

Alexza's policy is to only provide guidance on product candidates and corporate goals for the future one to two fiscal quarters, and to provide, update or reconfirm its guidance only by issuing a press release or filing updated guidance with the SEC in a publicly accessible document. Clinical and corporate milestones guidance is as of May 9, 2011 and financial guidance relating to the Company's current cash, cash equivalents and investments is based upon balances as of March 31, 2011, plus the net proceeds from the equity offering completed in May 2011.

This news release and anticipated conference call will contain forward-looking statements that involve significant risks and uncertainties. Any statement describing the Company's expectations or beliefs is a forward-looking statement, as defined in the Private Securities Litigation Reform Act of 1995, and should be considered an at-risk statement. Such statements are subject to certain risks and uncertainties, particularly those inherent in the process of developing and commercializing drugs including the adequacy of the Company's capital to support the Company's current operations through the projected timeframe, the potential of the Company's planned AZ-004 NDA resubmission to adequately address the issues in the CRL, the eventual prospects that AZ-004 will be approved for marketing and the timing of the Company's resubmission of the AZ-004 NDA to the FDA. The Company's forward-looking statements also involve assumptions that, if they prove incorrect, would cause its results to differ materially from those expressed or implied by such forward-looking stat
'/>"/>

SOURCE Alexza Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Alexza to Present at the MDB Bright Lights Conference 2011
2. Alexza Prices $16.1 Million Registered Direct Offering
3. Alexza Reports 2010 Fourth Quarter and Full Year Financial Results and Provides General Corporate Update
4. Alexza to Announce 2010 Year-End Financial Results on Tuesday, March 15, 2011
5. Alexza Pharmaceuticals Completes End-of-Review Meeting With FDA for AZ-004 (Staccato® Loxapine) NDA
6. Alexza Pharmaceuticals Provides Regulatory Update for AZ-004 (Staccato® Loxapine)
7. Alexza Pharmaceuticals Reports 2010 Third Quarter Financial Results and Provides Business Update
8. Alexza Pharmaceuticals to Announce 2010 Third Quarter Financial Results on November 9, 2010
9. Alexza Pharmaceuticals Reacquires U.S. and Canadian Rights for AZ-004 (Staccato® Loxapine)
10. Valeant Pharmaceuticals Announces That Alexza Pharmaceuticals Has Received a Complete Response Letter for AZ-004 (Staccato® Loxapine) Inhalation Aerosol NDA
11. Alexza Pharmaceuticals Receives Complete Response Letter for AZ-004 (Staccato® Loxapine) NDA
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2015)... 2015  CipherHealth, a leading provider of innovations and ... sent representatives to the Nepalese American Nursing Association to ... nurses to Nepal to aid ... month. In addition to helping fund the travel costs ... for much-needed medical supplies for the mission.  ...
(Date:5/5/2015)... , May 5, 2015   InspireMD, Inc. ... embolic protection systems, announced today that it will release its ... 2015 on Monday, May 11 th before the open, ... review its financial results and business outlook. Participants ... or (412) 542-4135 (International) and request the InspireMD call. A ...
(Date:5/5/2015)...  Trovagene, Inc. (NASDAQ:  TROV), a developer of ... for the three months ended March 31, 2015. ... presented favorable clinical results at ASCO GI, AACR, ... Precision Cancer Monitoring platform,s ability to detect and ... cancers," said Antonius Schuh, Ph.D., chief executive officer ...
Breaking Medicine Technology:Five Nurses and Medical Supplies En Route to Nepal With Donation Assistance from CipherHealth 2InspireMD to Report Financial Results for the First Quarter Ended March 31, 2015 on Monday, May 11th 2InspireMD to Report Financial Results for the First Quarter Ended March 31, 2015 on Monday, May 11th 3Trovagene, Inc. Announces First Quarter 2015 Financial Results 2Trovagene, Inc. Announces First Quarter 2015 Financial Results 3Trovagene, Inc. Announces First Quarter 2015 Financial Results 4Trovagene, Inc. Announces First Quarter 2015 Financial Results 5Trovagene, Inc. Announces First Quarter 2015 Financial Results 6
... , , WASHINGTON, Dec. 8 A ... wise choice in today,s economy. The Bureau of Labor Statistics, ... faster than for the average occupation--up to a 32 percent ... part of the pharmacy team and are relied upon to ...
... Dec. 8 Micromet, Inc. (Nasdaq: MITI ), ... treatment of cancer, inflammation and autoimmune diseases, today announced ... blinatumomab in patients with B-precursor acute lymphoblastic leukemia (ALL). ... the 51st Annual Meeting of the American Society of ...
Cached Medicine Technology:Pharmacy Technician Employment Increasing Up to 32% By 2016 2Final Data from Phase 2 Study Confirm High Response Rate of Micromet's Blinatumomab in Patients with Acute Lymphoblastic Leukemia 2Final Data from Phase 2 Study Confirm High Response Rate of Micromet's Blinatumomab in Patients with Acute Lymphoblastic Leukemia 3Final Data from Phase 2 Study Confirm High Response Rate of Micromet's Blinatumomab in Patients with Acute Lymphoblastic Leukemia 4
(Date:5/6/2015)... May 06, 2015 The beverage industry ... drinks. Little Miracles organic tea and superfruit fusions stands ... ginseng and sweetened with agave, these delicious juice blends ... that seeks healthier ways to hydrate. , In collaboration ... invites people to raise a bottle of Lemongrass Tea ...
(Date:5/5/2015)... (PRWEB) May 05, 2015 The ... Florida Hospital Tampa has been recognized by the ... Level 4 Epilepsy Center. The role of a ... diagnosis of a patient’s seizure type and seizure ... caregivers, appropriate treatment specific to a patient’s diagnosis ...
(Date:5/5/2015)... Scottsdale, AZ (PRWEB) May 05, 2015 ... NCPDP’s Elite Partner Program. The program establishes a three-year ... to a maximum of 10 Elite Partners. “AmerisourceBergen has ... Ann Stember, President of NCPDP, “and this is a ... work. , We can trace AmerisourceBergen back to ...
(Date:5/5/2015)... Washington, DC (PRWEB) May 05, 2015 ... ( Optimity) will present at the ... 20 at 1:15 p.m. MT in Scottsdale, AZ. ... the nation’s leading nonprofit authority on the use ... information exchange. Donald Graf, National Director of Telemedicine ...
(Date:5/5/2015)... Dallas, TX (PRWEB) May 05, 2015 ... has selected C.R. Bard Inc., a leading multinational ... technologies in the fields of vascular, urology, oncology ... its 2015 Vanguard Award. The Vanguard Award ... of employee wellness programs among Viverae’s significant client ...
Breaking Medicine News(10 mins):Health News:Say Cheers to National Beverage Day with Little Miracles 2Health News:Florida Hospital Tampa Epilepsy Program Earns Designation as a Level 4 Epilepsy Center by the National Association of Epilepsy Centers (NAEC) 2Health News:AmerisourceBergen Joins NCPDP Elite Partner Program 2Health News:AmerisourceBergen Joins NCPDP Elite Partner Program 3Health News:Optimity Advisors’ Hiliary Critchley, Telemedicine Expert, to Speak at WEDI Conference May 20th in Scottsdale, AZ 2Health News:Viverae® Honors C. R. Bard, Inc. with 2015 Vanguard Award 2
... in serious trouble after an eye infection was detected in ... products.// There are complaints arising from Asia, US and Europe ... might be linked to a spate of serious eye infections ... cases of the infection had also been confirmed in Europe. ...
... Dominique Samuels, whose burned body was found on Sunday, has ... nearby gas stations. //Police hope to find if anyone filled ... scouring gas stations near Franklin Park where the body was ... killed somewhere else before her body was moved to a ...
... poor quality of drinking water for the cholera cases that ... cases have been reported.// ,"The capital has reported 222 ... year. But we are not triggering the warning bell as ... municipal health officer of Delhi. ,"Waterborne diseases may ...
... which may be helpful in reducing the risk of ... more research is needed before it is implemented.// ... breast cancer through research and education in UK revealed ... 16 years, reported the online edition of Daily Mail. ...
... Doctors belonging to a hospital in Delhi is said to ... on Thursday. //They further claimed that the patient is the ... Sir Ganga Ram Hospital said that the girl from Gurgaon ... north India so far. ,"The child was suffering ...
... an explanation from the medical superintendent (MS) of the AIIMS ... inflicted with AIDS after undergoing blood transfusion in 2001. //The ... relevant documents were not being made available despite repeated requests. ... transfusion was the business of the public at large and ...
Cached Medicine News:
...
...
... Retriever is for arthroscopic and open soft tissue ... complicated procedural steps. It may be used ... and in conjunction with,anchors or screws (including suture ... needle tip permits the placement of a variety ...
Single step suture passage is made simple with Arthro-Pierce instruments. The low profile, highly sharpened tip allows easy passage through tissue in order to retrieve or apply suture....
Medicine Products: